Reuters logo
BRIEF-Ovid Therapeutics Q1 loss per share $3.48
2017年6月13日 / 晚上8点11分 / 3 个月前

BRIEF-Ovid Therapeutics Q1 loss per share $3.48

June 13 (Reuters) - Ovid Therapeutics Inc:

* Ovid Therapeutics reports first quarter 2017 financial results and recent corporate progress

* Q1 loss per share $3.48

* Q1 earnings per share view $-0.87 -- Thomson Reuters I/B/E/S

* Ovid Therapeutics Inc says company expects topline data to evaluate ov101 to be available in second half of 2017. Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below